, Tracking Stock Market Picks
Enter Symbol:
Idenix Pharmaceuticals, Inc. (IDIX) [hlAlert]

up 165.43 %

Idenix Pharmaceuticals, Inc. (IDIX) rated Buy with price target $11 by Maxim Group

Posted on: Thursday,  Jun 14, 2012  8:25 AM ET by Maxim Group

Maxim Group rated Buy Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) on 06/14/2012, when the stock price was $9.23. Since
then, Idenix Pharmaceuticals, Inc. has gained 165.44% as of 08/05/2014's recent price of $24.50.
If you would have followed this Maxim Group's recommendation on IDIX, you would have gained 165.43% of your investment in 782 days.

Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/14/2012 8:25 AM Buy
9.23 11.00
as of 12/31/2012
1 Week down  -0.61 %
1 Month down  -5.08 %
3 Months up  6.35 %
1 YTD down  -47.45 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy